Haisco Pharmaceutical Group's high P/E ratio is concerning d...
Haisco Pharmaceutical Group's high P/E ratio is concerning due to its poor earnings forecast. The inflated P/E from recent momentum may not be sustainable, posing a risk to shareholders and potential investors.
What Haisco Pharmaceutical Group Co., Ltd.'s (SZSE:002653) 26% Share Price Gain Is Not Telling You
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment